A stable isotope dilution assay for the in vivo determination of insulin levels in humans by mass spectrometry

Diabetes

Volumn 46, Issue 1, 1997, Pages 44-50

  Stöcklin, Reto ^a,c   Vu, Lan ^a   Vadas, Laszlo ^b   Cerini, Fabrice ^a   Kippen, Alistair D ^a   Offord, Robin E ^a   Rose, Keith ^a  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c ATHERIS LABORATORIES   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

EID: 0038478994     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.46.1.44     Document Type: Article

References (45)

1. Davidson HW, Rhodes CJ, Hutton JC: Intraorganellar calcium and pH control proinsulin cleavage in the pancreatic beta cell via two distinct site-specific endopeptidases. Nature 333:93-96, 1988
2. Lande S, Roder ME, Hartling SG, Binder C, Welinder BS: Separation and quantitation of serum proinsulin and proinsulin intermediates in humans. J Chromatogr 548:371-380, 1991
3. Linde S, Welinder BS, Nielsen JH: Analysis of proinsulin and its conversion products by reversed-phase high-performance liquid chromatography. J Chromatogr 614:185-204, 1993
4. Smeekens SP, Montag AG, Thomas G, Albiges-Rizo C, Carroll R, Benig M, Philips LA, Martin S, Ohagi S, Gardner P, Swift HH, Steiner DF: Proinsulin processing by the subtilisin-related proprotein convertases furin, PC2 and PC3. Proc Natl Acad Sci USA 89:8822-8826, 1992
5. Vollenweider F, Kaufmann J, Irminger J-C, Halban PA: Processing of proinsulin by furin, PC2, and PC3 in (Co) transfected COS (monkey kidney) cells. Diabetes 44:1075-1080, 1995
6. Halban PA, Irminger J-C: Sorting and processing of secretory proteins. Biochem J 299:1-18, 1994
7. Nagi DK, Hendra TJ, Ryle AJ, Cooper TM, Temple RC, Clark PMS, Schneider CN, Yudkin JS: The relationships of concentrations of insulin, intact proinsulin and 32-33 split proinsulin with cardiovascular risk factor in type 2 (non-insulin-dependent) diabetic subjects. Diabetologia 33:532-537, 1990
8. White MF, Kahn CR: The insulin signaling system. J Biol Chem 269:1-4, 1994
9. Yudkin JS: Circulating proinsulin-like molecules. J Diabetes Complications 7:113-123, 1993
10. Carpentier JL, Gorden P, Lew DP: Calcium ions are required for the intracellular routing of insulin and its receptor. Exp Cell Res 198:144-149, 1992
11. Duckworth WC: Insulin degradation: mechanisms, products, and significance. Endocr Rev 9:319-345, 1988
12. Fawcett J, Rabkin R: Sequential processing of insulin by cultured kidney cells. Endocrinology 136:39-45, 1995
13. Vu L, Stöcklin R, Rose K, Offord RE: Facile identification by electrospray mass spectrometry of the insulin fragment A14-21:B17-30 produced by insulin proteinase. Rapid Comm Mass Spectrom 7:1048-1050, 1993
14. Wroblewski VJ, Masnyk M, Khambatta SS, Becker GW: Mechanisms involved in degradation of human insulin by cytosolic fractions of human, monkey, and rat liver. Diabetes 41:539-547, 1992
15. Yalow RS, Berson SA: Assay of plasma insulin in human subjects by immunological methods. Nature 184:1648-1649, 1959
16. Kjems LL, Roder ME, Dinesen B, Hartling SG, Jorgensen PN, Binder C: Highly sensitive enzyme immunoassay of proinsulin immunoreactivity with use of two monoclonal antibodies. Clin Chem 39:2146-2150, 1993
17. Tietz NW: Clinical Guide to Laboratory Tests. 2nd ed. Philadelphia, WB Saunders, 1990, p. 1-333
18. Saric T, Seitz HJ, Pavelic K: Detection of the substance immunologically cross-reactive with insulin in insulin RIA is an artifact caused by insulin tracer degradation: involvement of the insulin-degrading enzyme. Mol Cell Endocrinol 106:23-29, 1994
19. Stumpo RR, Llera AS, Cardoso AI, Poskus E: Solid versus liquid phase assays in detection of insulin antibodies. Influence of iodination site on labelled insulin binding. J Immunol Methods 169:241-249, 1994
20. Temple RC, Clark PM, Nagi DK, Schneider AE, Yudkin JS, Hales C: Radioimmunoassay may overestimate insulin in non-insulin-dependent diabetics. Clin Endocrinol 32:689-693, 1990
21. Clark PM, Levy JC, Cox L, Burnett M, Turner RC, Hales CN: Immunoradiometric assay for insulin, intact proinsulin and 32-33 split proinsulin and radioimmunoassay of insulin in diet-treated type 2 (non-insulin-dependent) diabetic subjects. Diabetologia 35:469-474, 1992
22. O'Rahilly S, Turner RC, Matthews DR: Impaired pulsatil secretion of insulin in relatives of patients with non-insulin-dependent diabetes. N Engl J Med 318:1225-1230, 1988
23. Sobey WJ, Beer SF, Carrington CA, Clark PM, Frank BH, Gray IP, Luzio SD, Owens DR, Schneider AE, Siddle K: Sensitive and specific two-site immunoradiometric assays for human insulin, proinsulin, 65-66 split and 32-33 split proinsulins. Biochem J 260:535-541, 1989
24. Pavelic L, Pavelic K, Vuk-Pavlovic S: Human mammary and bronchial carcinomas: in vivo and in vitro secretion of substances immunologically cross-reactive with insulin. Cancer 53:2467-2471, 1984
25. Blackard WG, Nelson NC: Portal and peripheral vein immunoreactive insulin concentrations before and after glucose infusion. Diabetes 19:302-306, 1970
26. Robbins DC, Tager HS, Rubenstein AH: Biologic and clinical importance of proinsulin. N Engl J Med 310:1165-1175, 1984
27. Davies JG, Cerini F, Bradshaw CG: Partially degraded forms of insulin in the circulation of the rat: are they produced at the receptor? In Insulin and the Cell Membrane. Klimes I, Howard BV, Kahn CR, Eds. Chur, Switzerland, Harwood Academic Publishers, 1990, p. 243-254
28. Morishima T, Pye S, Bradshaw C, Radziuk J: Posthepatic rate of appearance of insulin: measurement and validation in the nonsteady state. Am J Physiol 263:E772-E779, 1992
29. Pye S, Watarai T, Davies G, Radziuk J: Comparison of the continuously calculated fractional splanchnic extraction of insulin with its fractional disappearance using a new double-tracer technique. Metabolism 42:145-153, 1993
30. 125I-labeled insulin in mice. Diabetes 39:563-569, 1990
31. Benzi L, Cecchetti P, Ciccarone A, Pilo A, Di Cianni G, Navalesi R Insulin degradation in vitro and in vivo: a comparative study in men: evidence that immunoprecipitable, partially rebindable degradation products are released from cells and circulate in blood. Diabetes 43:297-304, 1994
32. Cockram CS, Jones RH, Boroujerdi MA, Sonksen P: Evidence for separate handling in vivo of different regions of the insulin molecule using A14- and B1-labeled insulin tracers. Diabetes 33:721-727, 1984
33. Bowers GNJ, Fassett JD, White E: Isotope dilution mass spectrometry and the National Reference System. Anal Chem 65:475R-479R, 1993
34. Dass C, Kusmierz JJ, Desiderio DM: Mass spectrometric quantification of endogenous beta-endorphin. Biol Mass Spectrom 20:130-138, 1991
35. Desiderio D: Quantitative analytical mass spectrometry of endogenous neuropeptides in human pituitaries. Life Sci 51:169-176, 1992
36. Dewey RS, Liesch JM, Williams HR, Sugg EE, Dolan CA, Davies P, Mumford RA, Albers Schonberg G: Purification and characterization by fast-atom-bombardment mass spectrometry of the polymorphonuclear-leucocyte-elastase-generated A alpha (1-21) fragment of fibrinogen from human blood after incubation with calcium ionophore A23187. Biochem J 281:519-524, 1992
37. Stöcklin R, Rose K, Green BN, Offord RE: The semisynthesis of porcine insulin and its characterization by mass spectrometry. Protein Eng 7:285-289, 1994
38. Bojesen G: Mixtures of porcine and bovine insulin analysed by fast atom bombardment mass spectrometry with selected ion monitoring. Biomed Environ Mass Spectrom 19:541-544, 1990
39. Heath TG, Thanabal V, Ye Q-Z: Rapid, accurate and sensitive determination of molecular weight of 15-N and 13-C labeled recombinant proteins by electrospray ionization mass spectrometry. Biotechnol Tech 7:367-372, 1993
40. Nelson RW, Krone JR, Bieber AL, Williams P: Mass spectrometric immunoassay. Anal Chem 67:1153-1158, 1995
41. Zaluzec EJ, Gage DA, Watson JT: Quantitative assessment of cysteine and cystine in peptides and proteins following organomercurial derivatisation and analysis by matrix-assisted laser desorption ionization mass spectrometry. J Am Soc Mass Spectrom 5:359-366, 1994
42. Rose K, De Pury H, Offord RE: Rapid preparation of human insulin and insulin analogues in high yields by enzyme-assisted semi-synthesis. Biochem J 211:671-676, 1983
43. Halban PA: Structural domains and molecular lifestyles of insulin and its precursors in the pancreatic beta cell. Diabetolagia 34:767-778, 1991
44. Kahn CR: Insulin action, diabetogenes, and the cause of type II diabetes. Diabetes 43:1066-1084, 1994
45. Porte D Jr: β-cells in type II diabetes mellitus. Diabetes 40:166-180, 1991